Post-COVID-۱۹ Complications and their Laboratory Findings: A Cohort Study

Type ۲ severe acute respiratory syndrome caused by coronavirus infection has become the most well-known pandemic infectious viral disease in the present century. This study aims to find out the post-COVID-۱۹ infection complications via a well-designed observational study. A total of ۹۸۶ recovered cases (only the period ranged between ۲ to ۳ months after recovery) were obtained from public and private hospitals in Kirkuk and Erbil governorates\Iraq. The admitted patients were asked to answer a questionnaire through interviews; the laboratory findings were obtained from the patients. The results suggested that approximately half of post-COVID-۱۹ patients (%۴۵.۶۰۶) were suffering from chest pain, while (%۳۲.۳۵۷) of the cases suffered headache and chest pain. Liver enzymes (ALT, AST, and ALP) showed abnormal percent values of ۳۸.۶,۲۴.۰۷, and ۲۶.۰۹, respectively. Renal function enzymes, mainly urea, were found to be abnormal in ۴۵.۳۷% of recovered individuals. Furthermore, abnormal LDH levels were found in (۷۷.۹%) of post-COVID-۱۹patients. This finding revealed that chest pain was an inflammatory condition and liver and renal enzyme disturbances, while elevation in LDH was the predominant long-term complication in post-COVID-۱۹ patients.

کلیدواژه ها:

Coronavirus ، Post COVID-۱۹ Complication ، LDH ، Chest pain